Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dithranol powder
190400000AACACA
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Ditropan 2.5mg/5ml elixir
0704020J0BCACAZ
|
Ditropan (Urinary Incontinence) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Ditropan XL 10mg tablets
0704020J0BCAFAT
|
Ditropan (Urinary Incontinence) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Ditropan XL 5mg tablets
0704020J0BCAGAS
|
Ditropan (Urinary Incontinence) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Diumide-K Continus tablets
0202080K0BCAAAB
|
Diumide-K Continus | Furosemide/potassium | Cardiovascular System | No data available |
|
Diuresal 500mg tablets
0202020L0BCADBI
|
Diuresal | Furosemide | Cardiovascular System | No data available |
|
Diuril 250mg tablets
0202010D0BCABCY
|
Diuril | Chlorothiazide | Cardiovascular System | No data available |
|
Diuril 250mg/5ml oral suspension
0202010D0BCAAAU
|
Diuril | Chlorothiazide | Cardiovascular System | No data available |
|
Diva 2000/35 tablets
1306020C0BDAAAA
|
Diva | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
|
Do-Do ChestEze tablets
030902000BEDAA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
Doans Backache Pills
0407010X0BPAAA0
|
Doans | Paracetamol combined preparations | Central Nervous System | No data available |
|
Dobutamine 250mg/20ml solution for infusion ampoules
0207010D0AAADAD
|
Dobutamine hydrochloride | Dobutamine hydrochloride | Cardiovascular System | No data available |
|
Dobutamine 250mg/20ml solution for infusion vials
0207010D0AAABAB
|
Dobutamine hydrochloride | Dobutamine hydrochloride | Cardiovascular System | No data available |
|
Dobutamine 250mg/50ml solution for infusion vials
0207010D0AAAFAF
|
Dobutamine hydrochloride | Dobutamine hydrochloride | Cardiovascular System | No data available |
|
Dobutamine 250mg/5ml solution for infusion ampoules
0207010D0AAAEAE
|
Dobutamine hydrochloride | Dobutamine hydrochloride | Cardiovascular System | No data available |
|
Dobutrex 250mg/20ml solution for infusion vials
0207010D0BBABAB
|
Dobutrex | Dobutamine hydrochloride | Cardiovascular System | No data available |
|
Docetaxel 140mg/7ml solution for infusion vials
0801050D0AAAHAH
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 160mg/16ml solution for infusion vials
0801050D0AAAGAG
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 160mg/8ml solution for infusion vials
0801050D0AAAIAI
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/0.5ml solution for infusion vials and diluent
0801050D0AAAAAA
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/0.72ml inf vials and diluent
0801050D0AAALAL
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/1ml solution for infusion vials
0801050D0AAACAC
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/2ml solution for infusion vials
0801050D0AAAEAE
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/2.88ml inf vials and diluent
0801050D0AAAMAM
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/2ml solution for infusion vials and diluent
0801050D0AAABAB
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.